Tina Joseph, PharmD, BCACP, assistant professor, college of pharmacy, Nova Southeastern University, discusses collaborative practice agreements between pharmacists and physicians, as well as the challenges with, and best practices for, successful implementation.
Tina Joseph, PharmD, BCACP, assistant professor, college of pharmacy, Nova Southeastern University, discusses collaborative practice agreements between pharmacists and physicians, as well as the challenges with, and best practices for, successful implementation.
Transcript
What is a collaborative practice agreement, and how is it used among pharmacists?
A pharmacist collaborative practice agreement is a formal agreement between a licensed provider, who would make diagnoses and supervise patient care, and then they can refer to a pharmacist underneath the protocol, and the pharmacist would be able to change medications, stop medications, start anything that they would want to or labs within a specific scope of practice. This is a really great opportunity for pharmacists to leverage their pharmacy services and help coordinate care.
What barriers exist for successful implementation of collaborative practice agreements?
So, there’s a few barriers to implementing collaborative practice agreements. I think the biggest one is having a strong relationship with the provider you want to have a collaborative practice agreement with. The problem with that is it can take a lot of time to develop trust and make sure that the provider feels very comfortable, but it’s a very important step. Some other barriers could be that pharmacists right now don’t have provider status, so it’s very difficult for pharmacists to bill for their services under Medicare Part D.
A few other barriers could be that a lot of patients don’t fully understand the expanded scope of pharmacists, so when you’re interacting with a patient, it may be the first time they’ve interacted with a pharmacist like that. The last barrier is that there’s a lot of different state laws for collaborative practice agreements. So, depending on the state you’re interacting in, you have to really pay attention to every single law that is particular to that state.
What best practices have been identified for successfully implementing collaborative practice agreements?
There are so many best practices or implementing collaborative practice agreement. We have the Asheville Project, we have the Diabetes Ten City Challenge, and time and time again it shows that pharmacists can improve patient care, reduce costs, and help with preventive care. A few of the other studies actually do help to show that physicians are supportive of pharmacists when they have the opportunity to work with them, and I think there’s a big stigma that physicians really don’t respect pharmacists or think that they’re trained enough. But in the experience form that program and also in my own experience, once the pharmacist can get comfortable with the physician, they feel much more comfortable to work with them and sign a collaborative practice agreement.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More